SOMANYCERA.NS(SOMANYCERA.NS)
SOMANYCERA.NS
No analyst ratings available
No analyst price targets available for SOMANYCERA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $31.08B | $33.44B | $35.77B |
| Low | $29.96B | $30.85B | $33.72B |
| High | $32.33B | $35.31B | $37.50B |
| EBITDA Avg | $2.90B | $3.12B | $3.33B |
| Low | $2.79B | $2.87B | $3.14B |
| High | $3.01B | $3.29B | $3.49B |
| EBIT Avg | $1.91B | $2.05B | $2.20B |
| Low | $1.84B | $1.90B | $2.07B |
| High | $1.99B | $2.17B | $2.30B |
| Net Income Avg | $1.09B | $1.33B | $1.69B |
| Low | $925M | $861M | $1.56B |
| High | $1.43B | $1.70B | $1.80B |
| EPS Avg | $26.51 | $32.43 | $41.13 |
| Low | $22.52 | $20.97 | $38.06 |
| High | $34.91 | $41.43 | $43.71 |
| Analysts (Rev / EPS) | 13 / 14 | 14 / 15 | 7 / 10 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $8.03B | $7.87B | $7.97B |
| Low | $8.03B | $7.87B | $7.97B |
| High | $8.03B | $7.87B | $7.97B |
| EBITDA Avg | $748M | $733M | $742M |
| Low | $748M | $733M | $742M |
| High | $748M | $733M | $742M |
| EBIT Avg | $493M | $483M | $489M |
| Low | $493M | $483M | $489M |
| High | $493M | $483M | $489M |
| Net Income Avg | $292M | $193M | $255M |
| Low | $292M | $193M | $255M |
| High | $292M | $193M | $255M |
| EPS Avg | $7.10 | $4.70 | $6.20 |
| Low | $7.10 | $4.70 | $6.20 |
| High | $7.10 | $4.70 | $6.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |